Differential Use of Screening Mammography in Older Women Initiating Metformin versus Sulfonylurea.
Jin-Liern HongLouise M HendersonMichele Jonsson FunkJennifer L LundJohn B BuseVirginia PateTil StürmerPublished in: Pharmacoepidemiology and drug safety (2017)
Metformin initiators were more likely to receive screening mammograms than sulfonylurea initiators pre- and post-initiation, indicating possible detection bias due to differential screening mammography. Researchers should be aware of the potential for more screening mammograms pre- and post-initiation when interpreting the findings of metformin on breast cancer incidence. Copyright © 2017 John Wiley & Sons, Ltd.